Dr. Brenda Gallie on Retinoblastoma

Dr. Gallie is Head of the Retinoblastoma Program at The Hospital for Sick Children, Paediatric Ocular Oncologist at Alberta Children’s Hospital, Professor at the University of Toronto, and Affiliated Scientist and Lead of Health Informatics Research in the University Health Network Techna Institute. Gallie completed a MD at Queen’s University, Residency at the University of Toronto and post-graduate research training at Memorial Sloan-Kettering Cancer Center. Gallie’s research has improved outcomes for children affected by retinoblastoma worldwide and revealed fundamental mechanisms underpinning the basic molecular genetics of cancers broadly. In 2014, Gallie was appointed to the Order of Canada in recognition of her pioneering research in retinoblastoma.